Lexitropsin is an experimental medication that has been studied for its potential use in the treatment of neurodegenerative diseases, particularly Alzheimer's disease. It is a derivative of the compound tramiprosate and is believed to act by modulating the aggregation of amyloid-beta peptides, which are associated with the development of amyloid plaques in the brains of Alzheimer's patients. Clinical studies and trials for Lexitropsin have been conducted to evaluate its efficacy and safety.
Articles by others on the same topic
There are currently no matching articles.